M&A - CalciMedica, Inc.

Form Type: 10-K

Filing Date: 2025-03-27

Corporate Action: Merger

Type: Update

Accession Number: 000095017025046035

Filing Summary: CalciMedica, Inc. officially filed its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company is emerging from a merger in which the formerly known Graybug Vision, Inc. completed its merger with Private CalciMedica on March 20, 2023, whereby Private CalciMedica became a wholly owned subsidiary of Graybug. Following the merger, the company was renamed CalciMedica, Inc. The report outlines the financial performance of the company, detailing significant losses anticipated in the future and the likelihood of needing substantial further funding for product development. CalciMedica highlights its reliance on clinical trials and the necessity for successful execution of strategic plans for continued market presence. It discusses general risks associated with biotechnology development, the effects of market regulations, and potential capital issues. Additionally, the number of shares outstanding as of March 21, 2025, is reported as 13,481,917. The company is classified as a non-accelerated filer and a smaller reporting company.

Document Link: View Document